Explainer
This page establishes a framework for readers to submit moderated reviews of their experiences with peptide suppliers. Reviews are limited to documentation quality, shipping transparency, COA verification, and customer service interactions — the same dimensions used in our supplier evaluation guide and rankings. They are not a venue for dosing discussion, medical advice, purchasing guidance, or vendor recommendations. Every submission is reviewed by a moderator before it is published, and no personally identifiable information is accepted or displayed. Reviews represent the opinions of the individuals who submitted them; they are not editorial endorsements, and this site does not rank, recommend, or direct readers to any supplier for purchasing purposes.
Readers who have interacted with a peptide supplier — for example, by requesting documentation, reviewing a COA, contacting customer service, or observing shipping and handling practices — may submit a review describing that experience. The submission form collects structured ratings and a written summary, all scoped to documentation and transparency dimensions. Submissions are reviewed by a moderator before publishing to ensure they fall within the allowed categories and do not contain prohibited content. The submission process is anonymous: no name, email, account, or identifier is required to submit a review, and no personally identifiable information is published.
Reviews must focus on supplier documentation quality and transparency — the same dimensions assessed in our supplier evaluation guide. The allowed categories below are deliberately framed around critical reading and documentation verification, not around personal use, efficacy, or purchasing decisions. A useful test: does your review help another reader evaluate this supplier's documentation practices? If yes, it belongs here. If it describes what you did with the product, how much you used, or whether to buy from this supplier, it does not.
FDA guidance on labeling requirements for Research Use Only (RUO) and Investigational Use Only (IUO) products, clarifying that RUO/IUO designations do not exempt products from FDA enforcement if therapeutic claims or human-use marketing is present.
FDA warning letters database showing enforcement actions against online peptide sellers who market products as research-use-only while making therapeutic claims, providing dosing guidance, or implying human use. Includes warning letters to Gram Peptides and others in the peptide space.
The following content is rejected during moderation, regardless of how it is phrased. These boundaries exist for the same reasons documented in our community guidelines: reader safety, legal exposure, and editorial integrity. A review that includes dosing information turns a documentation assessment into a treatment record. A review that recommends a vendor turns a critical evaluation into purchasing guidance. Both contradict the site's role as an information index and the regulatory framework the FDA has cited in warning letters to sellers who provide dosing or human-use guidance.
FDA guidance on labeling requirements for Research Use Only (RUO) and Investigational Use Only (IUO) products, clarifying that RUO/IUO designations do not exempt products from FDA enforcement if therapeutic claims or human-use marketing is present.
FDA warning letter discussing peptide products marketed online and the limits of research-use-only positioning.
FDA warning letters database showing enforcement actions against online peptide sellers who market products as research-use-only while making therapeutic claims, providing dosing guidance, or implying human use. Includes warning letters to Gram Peptides and others in the peptide space.
FDA's MedWatch program for reporting adverse events, product quality problems, and medication errors related to FDA-regulated products including compounded drugs. Voluntary for consumers, mandatory for certain healthcare entities. There is no equivalent reporting system for RUO-sourced products.
Every submitted review is held for moderator review before publishing. No review is published automatically. Moderation checks each submission against the allowed and not-allowed categories defined above, verifies that no personally identifiable information is present, and confirms that the structured ratings and written summary stay within the documentation-quality scope. The moderation process is documented in the site's refresh log so the community can see what was accepted, rejected, and why — without identifying contributors.
Every published review follows the same structured format. This consistency ensures that reviews are comparable across suppliers, focused on documentation quality, and easy for readers to evaluate critically. The structure mirrors the six-dimension evaluation framework in our supplier evaluation guide, condensed into the dimensions most observable by a reader interacting with a supplier's documentation and service.
Published reviews represent the opinions and experiences of the individuals who submitted them. They are not editorial endorsements, not purchasing recommendations, and not assessments of product safety, efficacy, or suitability for any use. This site does not recommend, rank for purchase, or direct readers to any supplier. A supplier with high documentation ratings in user reviews may still sell products that are mislabeled, contaminated, or degraded — documentation quality is a proxy for operational transparency, not a guarantee of product quality. Readers should apply the same critical-reading framework to user reviews as they would to any community-sourced information: identify the source, check whether claims are verifiable, and weigh the review against independent evidence.
FDA guidance on labeling requirements for Research Use Only (RUO) and Investigational Use Only (IUO) products, clarifying that RUO/IUO designations do not exempt products from FDA enforcement if therapeutic claims or human-use marketing is present.
FDA warning letters database showing enforcement actions against online peptide sellers who market products as research-use-only while making therapeutic claims, providing dosing guidance, or implying human use. Includes warning letters to Gram Peptides and others in the peptide space.
Research-use-only peptide suppliers ranked by COA transparency, third-party testing, and customer reporting — the editorially maintained documentation assessment.
The six-dimension documentation checklist that user reviews are based on: COA policy, third-party testing, batch tracking, shipping, customer service, and warning letter history.
What is and is not allowed in reader-contributed content — including supplier reviews, survey responses, and comments.
Detailed guide to understanding HPLC, mass spectrometry, purity percentages, and red flags on peptide COAs.
How to evaluate marketplace listings, vendor claims, and red flags without buying.
Full list of tracked FDA, peer-reviewed, and community sources backing this page.
Free report
A practical checklist for reviewing RUO supplier pages, telehealth pages, supplies, and operator-stack claims without confusing the regulatory lane.
V1 collects email, role, and topic interest only. No medication, health-condition, dosing, or current-use data is collected in this form.
This explainer is informational. It does not recommend one access path over another, provide medical advice, or evaluate whether any compound is appropriate for human use. Both paths carry risks, and most peptides discussed online lack sufficient human clinical trial data for their popular uses.
Source records are stored in the repo and linked from each section.
FDA guidance on labeling requirements for Research Use Only (RUO) and Investigational Use Only (IUO) products, clarifying that RUO/IUO designations do not exempt products from FDA enforcement if therapeutic claims or human-use marketing is present.
FDA warning letter discussing peptide products marketed online and the limits of research-use-only positioning.
FDA warning letters database showing enforcement actions against online peptide sellers who market products as research-use-only while making therapeutic claims, providing dosing guidance, or implying human use. Includes warning letters to Gram Peptides and others in the peptide space.
FDA's MedWatch program for reporting adverse events, product quality problems, and medication errors related to FDA-regulated products including compounded drugs. Voluntary for consumers, mandatory for certain healthcare entities. There is no equivalent reporting system for RUO-sourced products.